| 摘要 |
PROBLEM TO BE SOLVED: To provide a new method for the treatment of inflammatory bowel disease (IBD), to provide a new pharmaceutical composition useful for the treatment of IBD, and to provide a method comprising a process for administering an anti-VLA (very late antigen)-4 antibody, such as antibody HP1/2, to an IBD patient (the employment of similar antibodies, antibody fragments, soluble proteins and small molecules similar to the action of an anti-VLA-4 antibody further for treatments of IBD are also considered). SOLUTION: A method for the treatment of inflammatory bowel disease (IBD) is disclosed. The method comprises administration of a VLA-4 antibody to a mammal diseased with inflammatory bowel disease, and the like. COPYRIGHT: (C)2007,JPO&INPIT
|
